BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17492740)

  • 1. Reactivity recognition by TRPA1 channels.
    Cebi M; Koert U
    Chembiochem; 2007 Jun; 8(9):979-80. PubMed ID: 17492740
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced activation of the transient receptor potential channel TRPA1 by ajoene, an allicin derivative.
    Yassaka RT; Inagaki H; Fujino T; Nakatani K; Kubo T
    Neurosci Res; 2010 Jan; 66(1):99-105. PubMed ID: 19808063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells.
    Louhivuori LM; Bart G; Larsson KP; Louhivuori V; Näsman J; Nordström T; Koivisto AP; Akerman KE
    J Cell Physiol; 2009 Oct; 221(1):67-74. PubMed ID: 19507192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPPB structure-specifically activates TRPA1 channels.
    Liu K; Samuel M; Ho M; Harrison RK; Paslay JW
    Biochem Pharmacol; 2010 Jul; 80(1):113-21. PubMed ID: 20226176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etodolac activates and desensitizes transient receptor potential ankyrin 1.
    Wang S; Dai Y; Kogure Y; Yamamoto S; Zhang W; Noguchi K
    J Neurosci Res; 2013 Dec; 91(12):1591-8. PubMed ID: 24027177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of TRPA1 by farnesyl thiosalicylic acid.
    Maher M; Ao H; Banke T; Nasser N; Wu NT; Breitenbucher JG; Chaplan SR; Wickenden AD
    Mol Pharmacol; 2008 Apr; 73(4):1225-34. PubMed ID: 18171730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural modeling and patch-clamp analysis of pain-related mutation TRPA1-N855S reveal inter-subunit salt bridges stabilizing the channel open state.
    Zíma V; Witschas K; Hynkova A; Zímová L; Barvík I; Vlachova V
    Neuropharmacology; 2015 Jun; 93():294-307. PubMed ID: 25724085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The exceptionally high reactivity of Cys 621 is critical for electrophilic activation of the sensory nerve ion channel TRPA1.
    Bahia PK; Parks TA; Stanford KR; Mitchell DA; Varma S; Stevens SM; Taylor-Clark TE
    J Gen Physiol; 2016 Jun; 147(6):451-65. PubMed ID: 27241698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritating channels: the case of TRPA1.
    Nilius B; Prenen J; Owsianik G
    J Physiol; 2011 Apr; 589(Pt 7):1543-9. PubMed ID: 21078588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRP channel activation by reversible covalent modification.
    Hinman A; Chuang HH; Bautista DM; Julius D
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19564-8. PubMed ID: 17164327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of significant amino acids in multiple transmembrane domains of human transient receptor potential ankyrin 1 (TRPA1) for activation by eudesmol, an oxygenized sesquiterpene in hop essential oil.
    Ohara K; Fukuda T; Okada H; Kitao S; Ishida Y; Kato K; Takahashi C; Katayama M; Uchida K; Tominaga M
    J Biol Chem; 2015 Jan; 290(5):3161-71. PubMed ID: 25525269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained TRPA1 activation in vivo.
    Koivisto A
    Acta Physiol (Oxf); 2012 Feb; 204(2):248-54. PubMed ID: 21518269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new tr(i)p to sense pain: TRPA1 channel as a target for novel analgesics.
    Cai X
    Expert Rev Neurother; 2008 Nov; 8(11):1675-81. PubMed ID: 18986238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.
    Stokes A; Wakano C; Koblan-Huberson M; Adra CN; Fleig A; Turner H
    Cell Signal; 2006 Oct; 18(10):1584-94. PubMed ID: 16500080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor.
    Defalco J; Steiger D; Gustafson A; Emerling DE; Kelly MG; Duncton MA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):276-9. PubMed ID: 19945872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor.
    Vallin KS; Sterky KJ; Nyman E; Bernström J; From R; Linde C; Minidis AB; Nolting A; Närhi K; Santangelo EM; Sehgelmeble FW; Sohn D; Strindlund J; Weigelt D
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5485-92. PubMed ID: 22868228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPA1 expression in human lingual nerve neuromas in patients with and without symptoms of dysaesthesia.
    Morgan CR; Bird EV; Robinson PP; Boissonade FM
    Neurosci Lett; 2009 Nov; 465(2):189-93. PubMed ID: 19715741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons.
    Anand U; Otto WR; Facer P; Zebda N; Selmer I; Gunthorpe MJ; Chessell IP; Sinisi M; Birch R; Anand P
    Neurosci Lett; 2008 Jun; 438(2):221-7. PubMed ID: 18456404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor.
    Brône B; Peeters PJ; Marrannes R; Mercken M; Nuydens R; Meert T; Gijsen HJ
    Toxicol Appl Pharmacol; 2008 Sep; 231(2):150-6. PubMed ID: 18501939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transnitrosylation directs TRPA1 selectivity in N-nitrosamine activators.
    Kozai D; Kabasawa Y; Ebert M; Kiyonaka S; ; Otani Y; Numata T; Takahashi N; Mori Y; Ohwada T
    Mol Pharmacol; 2014 Jan; 85(1):175-85. PubMed ID: 24202912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.